ARCHIVES

Reviewers Find I-ELCAP Is A Trial That Never Ends, With 90 Percent of Consent Forms Unobtainable

This article is from The Cancer Letter archive.

Vol. 37 No. 17 | April 29, 2011

Download PDF Visit The Full Archive

Related Articles

AGS-003 Immunotherapy Induces T Cell Responses in Phase II Trial

November 29, 2013

DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates

July 13, 1984

ACCC 10th Anniversary Meeting Zeroes in On Impact Of DRGs

February 24, 1984

Cancer Informatics: NCI Writing Dictionary To Standardize Data Reported In Trials

November 13, 1998

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014

Organ Systems Program to Submit 10 More Concepts In Fall

July 10, 1987